meta:
  schema_version: '1.0'
  cell_type: Tumor
  total_entries: 14
  generated_by: Dawn (literature curation)
  last_updated: '2026-02-13'
perturbations:
- id: TP53_KO_TUMOR
  gene: TP53
  gene_full_name: Tumor Protein P53
  perturbation_type: knockout
  context: in_vitro
  phenotype_changes:
  - parameter: proliferation
    direction: increase
    effect_size: 0.6
    confidence: high
  - parameter: apoptosis_resistance
    direction: increase
    effect_size: 0.75
    confidence: high
  - parameter: genomic_instability
    direction: increase
    effect_size: 0.55
    confidence: high
  cellswarm_mapping:
    behavior_changes:
      proliferate: 0.2
      apoptosis: -0.25
      evade: 0.1
    state_changes:
      proliferation_rate: 0.25
      apoptosis_susceptibility: -0.4
      immune_evasion: 0.1
  evidence:
  - description: p53 in tumor suppression and immune regulation. Kastenhuber & Lowe.
      Cell 2017
    pmid: '28886379'
    pmid_verified: true
  notes: p53 loss removes the major cell cycle checkpoint and apoptosis trigger
  data_calibration:
    source: Replogle et al. 2022 (Cell), K562 Perturb-seq
    replogle_id: 9195_TP53_P1P2_ENSG00000141510
    pathway_effects:
      proliferation:
        mean_effect: -0.0051
        max_effect: 0.1098
        min_effect: -0.0988
        n_markers: 6
      apoptosis:
        mean_effect: 0.0448
        max_effect: 0.1363
        min_effect: -0.0906
        n_markers: 5
      immune_evasion:
        mean_effect: 0.0595
        max_effect: 0.1411
        min_effect: -0.0561
        n_markers: 3
      migration:
        mean_effect: -0.0614
        max_effect: -0.0614
        min_effect: -0.0614
        n_markers: 1
      inflammation:
        mean_effect: 0.046
        max_effect: 0.0636
        min_effect: 0.0285
        n_markers: 2
- id: MYC_OE_TUMOR
  gene: MYC
  gene_full_name: MYC Proto-Oncogene
  perturbation_type: overexpression
  context: in_vitro
  phenotype_changes:
  - parameter: proliferation
    direction: increase
    effect_size: 0.8
    confidence: high
  - parameter: immune_evasion
    direction: increase
    effect_size: 0.45
    confidence: medium
  - parameter: pd_l1_expression
    direction: increase
    effect_size: 0.35
    confidence: medium
  cellswarm_mapping:
    behavior_changes:
      proliferate: 0.3
      evade: 0.15
      signal: 0.05
    state_changes:
      proliferation_rate: 0.35
      immune_evasion: 0.2
  evidence:
  - description: MYC drives immune evasion via PD-L1 and CD47. Casey et al. Science
      2016
    pmid: '27113275'
    pmid_verified: true
  notes: MYC directly upregulates PD-L1 and CD47, creating an immune-privileged niche
  data_calibration:
    source: Replogle et al. 2022 (Cell), K562 Perturb-seq
    replogle_id: 5374_MYC_P1P2_ENSG00000136997
    pathway_effects:
      proliferation:
        mean_effect: 0.0506
        max_effect: 0.1295
        min_effect: -0.0677
        n_markers: 6
      apoptosis:
        mean_effect: -0.0425
        max_effect: 0.0181
        min_effect: -0.1699
        n_markers: 5
      immune_evasion:
        mean_effect: 0.1321
        max_effect: 0.3266
        min_effect: 0.0168
        n_markers: 3
      migration:
        mean_effect: -0.2574
        max_effect: -0.2574
        min_effect: -0.2574
        n_markers: 1
      inflammation:
        mean_effect: 0.0398
        max_effect: 0.1884
        min_effect: -0.1088
        n_markers: 2
- id: CD274_OE_TUMOR
  gene: CD274
  gene_full_name: CD274 Molecule (PD-L1)
  perturbation_type: overexpression
  context: tumor_infiltrating
  phenotype_changes:
  - parameter: immune_evasion
    direction: increase
    effect_size: 0.7
    confidence: high
  - parameter: t_cell_exhaustion_induction
    direction: increase
    effect_size: 0.6
    confidence: high
  cellswarm_mapping:
    behavior_changes:
      evade: 0.3
      signal: 0.1
    state_changes:
      immune_evasion: 0.4
  evidence:
  - description: Tumor PD-L1 promotes immune evasion. Dong et al. Nat Med 2002
    pmid: '12091876'
    verified: true
  notes: PD-L1 overexpression is the primary adaptive immune resistance mechanism
- id: B2M_KO_TUMOR
  gene: B2M
  gene_full_name: Beta-2-Microglobulin
  perturbation_type: knockout
  context: tumor_infiltrating
  phenotype_changes:
  - parameter: mhc_i_expression
    direction: decrease
    effect_size: -0.95
    confidence: high
  - parameter: cd8_t_cell_recognition
    direction: decrease
    effect_size: -0.85
    confidence: high
  - parameter: nk_cell_susceptibility
    direction: increase
    effect_size: 0.4
    confidence: medium
  cellswarm_mapping:
    behavior_changes:
      evade: 0.35
      proliferate: 0.05
    state_changes:
      immune_evasion: 0.5
  evidence:
  - description: B2M loss as immunotherapy resistance mechanism. Zaretsky et al. NEJM
      2016
    pmid: '27433843'
    pmid_verified: true
  notes: B2M loss abolishes MHC-I surface expression; complete escape from CD8 T cells
    but increased NK sensitivity
  data_calibration:
    source: Replogle et al. 2022 (Cell), K562 Perturb-seq
    replogle_id: 724_B2M_P2_ENSG00000166710
    pathway_effects:
      proliferation:
        mean_effect: -0.0323
        max_effect: 0.1389
        min_effect: -0.1033
        n_markers: 6
      apoptosis:
        mean_effect: 0.0067
        max_effect: 0.1096
        min_effect: -0.1189
        n_markers: 5
      immune_evasion:
        mean_effect: -0.0438
        max_effect: 0.0949
        min_effect: -0.3152
        n_markers: 3
      migration:
        mean_effect: -0.0064
        max_effect: -0.0064
        min_effect: -0.0064
        n_markers: 1
      inflammation:
        mean_effect: 0.002
        max_effect: 0.0635
        min_effect: -0.0595
        n_markers: 2
- id: BRCA1_KO_TUMOR
  gene: BRCA1
  gene_full_name: BRCA1 DNA Repair Associated
  perturbation_type: knockout
  context: in_vitro
  phenotype_changes:
  - parameter: genomic_instability
    direction: increase
    effect_size: 0.7
    confidence: high
  - parameter: neoantigen_load
    direction: increase
    effect_size: 0.5
    confidence: medium
  - parameter: parp_inhibitor_sensitivity
    direction: increase
    effect_size: 0.85
    confidence: high
  cellswarm_mapping:
    behavior_changes:
      proliferate: 0.05
      apoptosis: 0.1
    state_changes:
      apoptosis_susceptibility: 0.2
      immune_evasion: -0.15
  evidence:
  - description: BRCA1 deficiency and immunogenicity. Strickland et al. Cell Rep 2016
    pmid: '28886379'
    pmid_verified: true
  notes: BRCA1 loss increases TMB and neoantigen load, making tumors more immunogenic
  data_calibration:
    source: Replogle et al. 2022 (Cell), K562 Perturb-seq
    replogle_id: 884_BRCA1_P1P2_ENSG00000012048
    pathway_effects:
      proliferation:
        mean_effect: 0.0194
        max_effect: 0.1123
        min_effect: -0.0249
        n_markers: 6
      apoptosis:
        mean_effect: -0.0133
        max_effect: 0.1028
        min_effect: -0.1138
        n_markers: 5
      immune_evasion:
        mean_effect: 0.0748
        max_effect: 0.1281
        min_effect: 0.0175
        n_markers: 3
      migration:
        mean_effect: -0.1772
        max_effect: -0.1772
        min_effect: -0.1772
        n_markers: 1
      inflammation:
        mean_effect: 0.1341
        max_effect: 0.2537
        min_effect: 0.0145
        n_markers: 2
- id: EGFR_OE_TUMOR
  gene: EGFR
  gene_full_name: Epidermal Growth Factor Receptor
  perturbation_type: overexpression
  context: in_vitro
  phenotype_changes:
  - parameter: proliferation
    direction: increase
    effect_size: 0.65
    confidence: high
  - parameter: survival_signaling
    direction: increase
    effect_size: 0.55
    confidence: high
  cellswarm_mapping:
    behavior_changes:
      proliferate: 0.25
      apoptosis: -0.1
      migrate: 0.05
    state_changes:
      proliferation_rate: 0.3
      apoptosis_susceptibility: -0.15
  evidence:
  - description: EGFR signaling in cancer. Sigismund et al. Curr Opin Cell Biol 2018
    pmid: '29124875'
    pmid_verified: true
  notes: EGFR amplification drives proliferation via RAS-MAPK and PI3K-AKT pathways
- id: CDH1_KO_TUMOR
  gene: CDH1
  gene_full_name: Cadherin 1 (E-cadherin)
  perturbation_type: knockout
  context: in_vitro
  phenotype_changes:
  - parameter: migration
    direction: increase
    effect_size: 0.7
    confidence: high
  - parameter: emt_score
    direction: increase
    effect_size: 0.65
    confidence: high
  - parameter: immune_evasion
    direction: increase
    effect_size: 0.3
    confidence: medium
  cellswarm_mapping:
    behavior_changes:
      migrate: 0.25
      evade: 0.1
      proliferate: -0.05
    state_changes:
      immune_evasion: 0.15
  evidence:
  - description: E-cadherin loss in EMT and metastasis. Dongre & Weinberg. Nat Rev
      Mol Cell Biol 2019
    pmid: '30459476'
    pmid_verified: true
  notes: E-cadherin loss triggers EMT, increasing motility and immune evasion
- id: JAK1_KO_TUMOR
  gene: JAK1
  gene_full_name: Janus Kinase 1
  perturbation_type: knockout
  context: tumor_infiltrating
  phenotype_changes:
  - parameter: ifn_gamma_response
    direction: decrease
    effect_size: -0.85
    confidence: high
  - parameter: pd_l1_induction
    direction: decrease
    effect_size: -0.7
    confidence: high
  - parameter: mhc_i_upregulation
    direction: decrease
    effect_size: -0.6
    confidence: high
  cellswarm_mapping:
    behavior_changes:
      evade: 0.25
      proliferate: 0.05
    state_changes:
      immune_evasion: 0.35
  evidence:
  - description: JAK1/2 loss as immunotherapy resistance. Manguso et al. Nature 2017
    pmid: '28723893'
    verified: true
  notes: JAK1 loss blocks IFN-gamma signaling; tumors become invisible to T cells
  data_calibration:
    source: Replogle et al. 2022 (Cell), K562 Perturb-seq
    replogle_id: 4247_JAK1_P1P2_ENSG00000162434
    pathway_effects:
      proliferation:
        mean_effect: 0.0483
        max_effect: 0.1163
        min_effect: -0.0459
        n_markers: 6
      apoptosis:
        mean_effect: -0.005
        max_effect: 0.1789
        min_effect: -0.0843
        n_markers: 5
      immune_evasion:
        mean_effect: -0.0021
        max_effect: 0.115
        min_effect: -0.0686
        n_markers: 3
      migration:
        mean_effect: -0.0514
        max_effect: -0.0514
        min_effect: -0.0514
        n_markers: 1
      inflammation:
        mean_effect: -0.1911
        max_effect: -0.1225
        min_effect: -0.2598
        n_markers: 2
- id: CTNNB1_OE_TUMOR
  gene: CTNNB1
  gene_full_name: Catenin Beta 1 (Beta-catenin)
  perturbation_type: overexpression
  context: tumor_infiltrating
  phenotype_changes:
  - parameter: t_cell_exclusion
    direction: increase
    effect_size: 0.55
    confidence: high
  - parameter: wnt_signaling
    direction: increase
    effect_size: 0.7
    confidence: high
  cellswarm_mapping:
    behavior_changes:
      evade: 0.2
      proliferate: 0.1
    state_changes:
      immune_evasion: 0.25
      proliferation_rate: 0.1
  evidence:
  - description: WNT/beta-catenin drives T cell exclusion. Spranger et al. Nature
      2015
    pmid: '26380088'
    pmid_verified: true
  notes: Activated beta-catenin suppresses CCL4, preventing DC recruitment and T cell
    priming
  data_calibration:
    source: Replogle et al. 2022 (Cell), K562 Perturb-seq
    replogle_id: 1937_CTNNB1_P1P2_ENSG00000168036
    pathway_effects:
      proliferation:
        mean_effect: -0.0273
        max_effect: 0.2694
        min_effect: -0.2229
        n_markers: 6
      apoptosis:
        mean_effect: 0.0302
        max_effect: 0.3382
        min_effect: -0.2309
        n_markers: 5
      immune_evasion:
        mean_effect: 0.0936
        max_effect: 0.254
        min_effect: -0.1468
        n_markers: 3
      migration:
        mean_effect: 0.0408
        max_effect: 0.0408
        min_effect: 0.0408
        n_markers: 1
      inflammation:
        mean_effect: -0.1484
        max_effect: -0.0808
        min_effect: -0.216
        n_markers: 2
- id: VEGFA_OE_TUMOR
  gene: VEGFA
  gene_full_name: Vascular Endothelial Growth Factor A
  perturbation_type: overexpression
  context: tumor_infiltrating
  phenotype_changes:
  - parameter: angiogenesis
    direction: increase
    effect_size: 0.75
    confidence: high
  - parameter: immune_suppression
    direction: increase
    effect_size: 0.4
    confidence: medium
  cellswarm_mapping:
    behavior_changes:
      signal: 0.15
      evade: 0.1
    state_changes:
      immune_evasion: 0.15
  evidence:
  - description: VEGF in tumor angiogenesis and immune evasion. Voron et al. J Exp
      Med 2015
    pmid: '25601652'
    pmid_verified: true
  notes: VEGF promotes abnormal vasculature and directly suppresses T cell function
  data_calibration:
    source: Replogle et al. 2022 (Cell), K562 Perturb-seq
    replogle_id: 9718_VEGFA_P1P2_ENSG00000112715
    pathway_effects:
      proliferation:
        mean_effect: 0.0221
        max_effect: 0.1223
        min_effect: -0.0607
        n_markers: 6
      apoptosis:
        mean_effect: -0.0119
        max_effect: 0.1153
        min_effect: -0.0811
        n_markers: 5
      immune_evasion:
        mean_effect: -0.0345
        max_effect: 0.0009
        min_effect: -0.0924
        n_markers: 3
      migration:
        mean_effect: 0.0179
        max_effect: 0.0179
        min_effect: 0.0179
        n_markers: 1
      inflammation:
        mean_effect: 0.1012
        max_effect: 0.1927
        min_effect: 0.0096
        n_markers: 2
- id: KRAS_G12D_TUMOR
  gene: KRAS
  gene_full_name: KRAS Proto-Oncogene GTPase
  perturbation_type: overexpression
  context: in_vitro
  phenotype_changes:
  - parameter: proliferation
    direction: increase
    effect_size: 0.7
    confidence: high
  - parameter: immune_evasion
    direction: increase
    effect_size: 0.35
    confidence: medium
  cellswarm_mapping:
    behavior_changes:
      proliferate: 0.25
      evade: 0.1
      signal: 0.05
    state_changes:
      proliferation_rate: 0.3
      immune_evasion: 0.1
  evidence:
  - description: Oncogenic KRAS drives immunosuppressive TME. Pylayeva-Gupta et al.
      Cancer Cell 2012
    pmid: '22698407'
    pmid_verified: true
  notes: KRAS G12D promotes GM-CSF secretion, recruiting MDSCs and suppressing anti-tumor
    immunity
  data_calibration:
    source: Replogle et al. 2022 (Cell), K562 Perturb-seq
    replogle_id: 4466_KRAS_P1P2_ENSG00000133703
    pathway_effects:
      proliferation:
        mean_effect: -0.0098
        max_effect: 0.1224
        min_effect: -0.078
        n_markers: 6
      apoptosis:
        mean_effect: -0.0063
        max_effect: 0.1144
        min_effect: -0.0749
        n_markers: 5
      immune_evasion:
        mean_effect: -0.0662
        max_effect: -0.0347
        min_effect: -0.1126
        n_markers: 3
      migration:
        mean_effect: -0.2211
        max_effect: -0.2211
        min_effect: -0.2211
        n_markers: 1
      inflammation:
        mean_effect: -0.033
        max_effect: -0.0255
        min_effect: -0.0404
        n_markers: 2
- id: TGFB1_OE_TUMOR
  gene: TGFB1
  gene_full_name: Transforming Growth Factor Beta 1
  perturbation_type: overexpression
  context: tumor_infiltrating
  phenotype_changes:
  - parameter: immune_exclusion
    direction: increase
    effect_size: 0.6
    confidence: high
  - parameter: emt_score
    direction: increase
    effect_size: 0.5
    confidence: high
  cellswarm_mapping:
    behavior_changes:
      evade: 0.2
      signal: 0.1
      migrate: 0.05
    state_changes:
      immune_evasion: 0.3
  evidence:
  - description: TGF-beta drives immune exclusion. Mariathasan et al. Nature 2018
    pmid: '29669246'
    pmid_verified: true
  notes: Tumor-derived TGF-beta creates a fibrotic barrier excluding T cells from
    tumor core
  data_calibration:
    source: Replogle et al. 2022 (Cell), K562 Perturb-seq
    replogle_id: 8859_TGFB1_P1P2_ENSG00000105329
    pathway_effects:
      proliferation:
        mean_effect: 0.0023
        max_effect: 0.1149
        min_effect: -0.1065
        n_markers: 6
      apoptosis:
        mean_effect: 0.043
        max_effect: 0.1079
        min_effect: -0.0583
        n_markers: 5
      immune_evasion:
        mean_effect: 0.0321
        max_effect: 0.0824
        min_effect: 0.0029
        n_markers: 3
      migration:
        mean_effect: 0.0086
        max_effect: 0.0086
        min_effect: 0.0086
        n_markers: 1
      inflammation:
        mean_effect: 0.0059
        max_effect: 0.0112
        min_effect: 0.0007
        n_markers: 2
- id: IDO1_OE_TUMOR
  gene: IDO1
  gene_full_name: Indoleamine 2,3-Dioxygenase 1
  perturbation_type: overexpression
  context: tumor_infiltrating
  phenotype_changes:
  - parameter: tryptophan_depletion
    direction: increase
    effect_size: 0.6
    confidence: high
  - parameter: t_cell_suppression
    direction: increase
    effect_size: 0.5
    confidence: high
  cellswarm_mapping:
    behavior_changes:
      evade: 0.2
      signal: 0.05
    state_changes:
      immune_evasion: 0.25
  evidence:
  - description: IDO in tumor immune escape. Munn & Mellor. J Clin Invest 2007
    pmid: '17476344'
    pmid_verified: true
  notes: IDO1 depletes tryptophan and generates kynurenine, suppressing T cells and
    promoting Tregs
- id: CD47_OE_TUMOR
  gene: CD47
  gene_full_name: CD47 Molecule
  perturbation_type: overexpression
  context: tumor_infiltrating
  phenotype_changes:
  - parameter: phagocytosis_evasion
    direction: increase
    effect_size: 0.7
    confidence: high
  - parameter: macrophage_suppression
    direction: increase
    effect_size: 0.5
    confidence: high
  cellswarm_mapping:
    behavior_changes:
      evade: 0.25
      proliferate: 0.05
    state_changes:
      immune_evasion: 0.3
  evidence:
  - description: CD47 as 'don't eat me' signal. Willingham et al. PNAS 2012
    pmid: '22451913'
    pmid_verified: true
  notes: CD47 binds SIRPa on macrophages to inhibit phagocytosis; overexpressed in
    most cancers
  data_calibration:
    source: Replogle et al. 2022 (Cell), K562 Perturb-seq
    replogle_id: 1367_CD47_P1P2_ENSG00000196776
    pathway_effects:
      proliferation:
        mean_effect: -0.0232
        max_effect: 0.0887
        min_effect: -0.1933
        n_markers: 6
      apoptosis:
        mean_effect: 0.0222
        max_effect: 0.1384
        min_effect: -0.0593
        n_markers: 5
      immune_evasion:
        mean_effect: 0.1735
        max_effect: 0.2293
        min_effect: 0.085
        n_markers: 3
      migration:
        mean_effect: -0.0608
        max_effect: -0.0608
        min_effect: -0.0608
        n_markers: 1
      inflammation:
        mean_effect: 0.0368
        max_effect: 0.0932
        min_effect: -0.0196
        n_markers: 2
